Histone deacetylase inhibitor sodium butyrate attenuates gentamicin-induced hearing loss in vivo
Histone deacetylase inhibitor sodium butyrate attenuates gentamicin-induced hearing loss in vivo
复制标题
组蛋白脱乙酰酶抑制剂丁酸钠可减轻庆大霉素引起的体内听力损失
DOI:
10.1016/j.amjoto.2014.11.003
复制
发表时间:
2015-03-01
影响因子:
2.5
通讯作者:
Chen, Fu-quan
中科院分区:
文献类型:
--
作者:
Wang, Jie;Wang, Ye;Chen, Fu-quan
Objective: Although histone deacetylase (HDAC) inhibition has been shown to protect against gentamicin (GM)-induced hearing loss in vitro, its protective effect has not been proven in vivo. In the present study, the aim was to investigate the protective effect of sodium butyrate (NaB), a specific HDAC inhibitor, on GM-induced ototoxicity in vivo.Methods: Forty 8-week-old albino guinea pigs were divided into two experimental groups. Group 1 (n = 10) underwent bilateral ear surgery to place sponges (0.3 mm(3)) permeated with NaB (10 mu l, 100 mg/ml) and physiological saline (10 mu l; control) in the right and left round window niches, respectively. The sponges were left in place for 15 days to evaluate the effects of NaB at the applied concentration. Group 2 (n = 30) underwent the same bilateral ear surgery described for Group 1, except three days after surgery, the animals received intramuscular GM injections (200 mg/kg/day) for 5 consecutive days. Seven days after the final GM injection, the protective effects of NaB were examined.Results: After 15 days of NaB treatment (10 mu l, 100 mg/ml), an increase in histone acetylation was detected in Corti organ samples. Auditory brainstem response (ABR) threshold shifts and hair cell loss were also reduced in NaB-treated ears after GM administration. Furthermore, GM treatment increased HDAC1 expression in outer hair cells (OHCs) in vivo, and NaB blocked this action.Conclusion: GM increases HDAC1 expression in OHCs, and NaB is able to block this action. Thus, it appears that the HDAC inhibitor, NaB, attenuates GM-induced hearing loss in guinea pigs. (C) 2015 Elsevier Inc. All rights reserved.